ResMed Inc. RMD
$231.43
+0.34%
at last close
Analyst Consensus
- Consensus Rating
- Hold (3 Buy · 9 Hold · 0 Sell)
- Average Price Target
- $238.09
- Implied Upside
- +2.9%
- Price Target Range
- $215.00 – $275.00
- Analysts (12 mo)
- 12
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-19 | Rothschild & CoJackson Philips |
Initiates coverage on | Neutral | $230 |
| 2026-08-07 | RBC CapitalCraig Wong-Pan |
Maintains | Sector perform | $234 → $244 |
| 2026-08-07 | Piper SandlerAdam Maeder |
Maintains | Neutral | $233 → $225 |
| 2026-08-07 | KeybancBrett Fishbin |
Maintains | Overweight | $260 → $255 |
| 2026-08-07 | Wells FargoNathan Treybeck |
Maintains | Equal-weight | $225 → $215 |
| 2026-07-15 | MizuhoAnthony Petrone |
Maintains | Outperform | $235 → $220 |
| 2026-07-13 | CitigroupLaura Sutcliffe |
Downgrades | Buy → Neutral | $270 → $235 |
| 2026-07-10 | JefferiesMatthew Taylor |
Maintains | Hold | $240 → $225 |
| 2026-07-08 | RBC CapitalCraig Wong-Pan |
Maintains | Outperform | $321 → $276 |
| 2026-07-08 | Wells FargoNathan Treybeck |
Maintains | Equal-weight | $227 → $225 |
| 2026-06-22 | KeybancJustin Patterson |
Maintains | Overweight | $290 → $266 |
| 2026-06-17 | Morgan StanleyDavid Bailey |
Downgrades | Overweight → Equal-weight | $286 → $230 |
| 2026-06-15 | CitigroupLaura Sutcliffe |
Maintains | Buy | $340 → $270 |
| 2026-05-01 | RBC CapitalCraig Wong-Pan |
Maintains | Outperform | $314 → $321 |
| 2026-05-01 | Wells FargoNathan Treybeck |
Maintains | Equal-weight | $270 → $227 |
| 2026-04-27 | KeybancBrett Fishbin |
Maintains | Overweight | $302 → $290 |
| 2026-04-15 | JP MorganDavid Low |
Reinstates | Overweight | — |
| 2026-04-09 | CitigroupLaura Sutcliffe |
Maintains | Buy | $345 → $340 |
| 2026-02-02 | CitigroupLaura Sutcliffe |
Maintains | Buy | $330 → $345 |
| 2026-01-30 | RBC CapitalCraig Wong-Pan |
Maintains | Outperform | $311 → $314 |
| 2026-01-30 | Piper SandlerAdam Maeder |
Maintains | Neutral | $270 → $275 |
| 2026-01-30 | Wells FargoNathan Treybeck |
Maintains | Equal-weight | $265 → $270 |
| 2026-01-30 | StifelJonathan Block |
Maintains | Hold | $260 → $265 |
| 2025-12-18 | StifelJonathan Block |
Maintains | Hold | $270 → $260 |
| 2025-12-16 | BairdJoe Vruwink |
Downgrades | Outperform → Neutral | $300 → $275 |
| 2025-11-03 | BairdJoe Vruwink |
Maintains | Outperform | $320 → $300 |
| 2025-10-31 | RBC CapitalCraig Wong-Pan |
Maintains | Outperform | $300 → $303 |
| 2025-10-31 | KeybancBrett Fishbin |
Maintains | Overweight | $298 → $299 |
| 2025-10-31 | MizuhoAnthony Petrone |
Maintains | Outperform | $310 → $300 |
| 2025-10-21 | Morgan StanleySean Laaman |
Maintains | Overweight | $298 → $304 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $231.43
- Market Cap
- $33.27 billion
- 52-Week Range
- $180.26 – $293.81
- Average Volume
- 1.37 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.